Aptar Pharma’s Ready-to-Use Program Facilitates Development Times
Pharma customers serving the biologics market require smaller manufacturing runs as these markets have a smaller subset of patients. As a result, contract partners must be able to provide Ready-To-Use (RTU) products that allow for faster and more flexible runs.
Pharma customers serving the biologics market require smaller manufacturing runs as these markets have a smaller subset of patients. As a result, contract partners must be able to provide Ready-To-Use (RTU) products that allow for faster and more flexible runs.
Aptar Pharma fulfills this request for customer by providing RTU stoppers. The stoppers, along with vials, and seals are available through Aptar’s QuickStart® for Injectables, a one-stop-shop, ready-to-use sterile solution, designed specifically to accelerate the development time for start-ups and early-stage development, R&D, biotechs, and university research organizations.
